COVID-19 Symptoms Are Attenuated in Moderate-to-Severe Atopic Dermatitis Patients Treated with Dupilumab
出版年份 2021 全文链接
标题
COVID-19 Symptoms Are Attenuated in Moderate-to-Severe Atopic Dermatitis Patients Treated with Dupilumab
作者
关键词
-
出版物
Journal of Allergy and Clinical Immunology-In Practice
Volume 10, Issue 1, Pages 134-142
出版商
Elsevier BV
发表日期
2021-11-01
DOI
10.1016/j.jaip.2021.10.050
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Long-term follow-up of recovered patients with COVID-19
- (2021) Monica Cortinovis et al. LANCET
- Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
- (2020) Chaolin Huang et al. LANCET
- An interactive web-based dashboard to track COVID-19 in real time
- (2020) Ensheng Dong et al. LANCET INFECTIOUS DISEASES
- Clinical Characteristics of Coronavirus Disease 2019 in China
- (2020) Wei-jie Guan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Dupilumab and COVID ‐19: What should we expect?
- (2020) Cataldo Patruno et al. Dermatologic Therapy
- Covid-19 and immunomodulation in IBD
- (2020) Markus F Neurath GUT
- Safety of dupilumab in atopic patients during COVID-19 outbreak
- (2020) Maddalena Napolitano et al. JOURNAL OF DERMATOLOGICAL TREATMENT
- Risk of hospitalization and death from COVID-19 infection in patients with chronic plaque psoriasis receiving a biologic treatment and renal transplant recipients in maintenance immunosuppressive treatment
- (2020) Paolo Gisondi et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- SARS‐CoV‐2 asymptomatic infection in a patient under treatment with dupilumab
- (2020) Francesca Caroppo et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Safety of dupilumab in severe atopic dermatitis and infection of Covid‐19: two case reports
- (2020) S. Ferrucci et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Elevated plasma level of selective cytokines in COVID-19 patients reflect viral load and lung injury
- (2020) Yingxia Liu et al. National Science Review
- Is asthma protective against COVID‐19?
- (2020) Giulia Carli et al. ALLERGY
- Management of adult patients with severe atopic dermatitis treated with dupilumab during COVID ‐19 pandemic: A single‐center real‐life experience
- (2020) Mariateresa Rossi et al. Dermatologic Therapy
- Circulating levels of IL‐2, IL‐4, TNF‐α, IFN‐γ, and C‐reactive protein are not associated with severity of COVID‐19 symptoms
- (2020) Wen Luo et al. JOURNAL OF MEDICAL VIROLOGY
- Risk of COVID-19 in dermatologic patients receiving long-term immunomodulatory therapy
- (2020) Zachary E. Holcomb et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Longitudinal analyses reveal immunological misfiring in severe COVID-19
- (2020) Carolina Lucas et al. NATURE
- Tape-Strip Proteomic Profiling of Atopic Dermatitis on Dupilumab Identifies Minimally Invasive Biomarkers
- (2020) Helen He et al. Frontiers in Immunology
- Risk factors for Covid-19 severity and fatality: a structured literature review
- (2020) Dominik Wolff et al. INFECTION
- Efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps (LIBERTY NP SINUS-24 and LIBERTY NP SINUS-52): results from two multicentre, randomised, double-blind, placebo-controlled, parallel-group phase 3 trials
- (2019) Claus Bachert et al. LANCET
- Dupilumab Efficacy in Patients With Uncontrolled, Moderate-to-Severe Allergic Asthma
- (2019) Jonathan Corren et al. Journal of Allergy and Clinical Immunology-In Practice
- Dupilumab progressively improves systemic and cutaneous abnormalities in atopic dermatitis patients
- (2018) Emma Guttman-Yassky et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Atopic Dermatitis in America Study: A Cross-Sectional Study Examining the Prevalence and Disease Burden of Atopic Dermatitis in the US Adult Population
- (2018) Zelma C. Chiesa Fuxench et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- A mild topical steroid leads to progressive anti-inflammatory effects in the skin of patients with moderate-to-severe atopic dermatitis
- (2016) Patrick M. Brunner et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Preseasonal treatment with either omalizumab or an inhaled corticosteroid boost to prevent fall asthma exacerbations
- (2015) Stephen J. Teach et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Cyclosporine in patients with atopic dermatitis modulates activated inflammatory pathways and reverses epidermal pathology
- (2014) Saakshi Khattri et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Progressive activation of TH2/TH22 cytokines and selective epidermal proteins characterizes acute and chronic atopic dermatitis
- (2012) Julia K. Gittler et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Reversal of atopic dermatitis with narrow-band UVB phototherapy and biomarkers for therapeutic response
- (2011) Suzanne Tintle et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Rhinovirus-induced lower respiratory illness is increased in asthma and related to virus load and Th1/2 cytokine and IL-10 production
- (2008) S. D. Message et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now